M2 Archive: Preview


You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.


Nuevolution applies for delisting of shares from Nasdaq Stockholm

Nuevolution AB (STO:NUE), a small molecule drug discovery biotechnology company, announced on Thursday that at the request of Amgen, the company's board of directors has resolved to apply for delisting of Nuevolution's shares from Nasdaq Stockholm.

Reportedly, the recommended public cash...  


If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search